Neoplasms, Colorectal Recruiting Phase 2 Trials for Pembrolizumab (DB09037)

Also known as: Colorectal Neoplasms / Colorectal Neoplasm / Neoplasms,Colorectal

IndicationStatusPhase
DBCOND0036298 (Neoplasms, Colorectal)Recruiting2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03519412Pembrolizumab in MMR-Proficient Metastatic Colorectal Cancer Pharmacologically Primed to Trigger Hypermutation StatusTreatment